John Soglia BS, PhD

John has 16+ years of experience leading drug disposition functions in both large pharmaceutical companies and small biotech. He has Extensive experience in the quantitative sciences and tools used to support R&D DMPK, unregulated and regulated bioanalysis, nonclinical and clinical pharmacokinetics and pharmacokinetic modelling and simulation. He has Comprehensive understanding of the preclinical and early clinical development process having led program teams to IND/CTA filing and FIH studies.
He has Global understanding of the drug disposition and clinical pharmacology requirements to support clinical program development having been a functional representative on programs that made it to market (NDA filing). He Proven his ability to build strong collaborations with contract research organizations to provide specialized support or extend internal R&D capabilities.